DRUG DEVELOPMENT, EVOLVED

DRUG DEVELOPMENT, EVOLVED

Animal testing is yesterday's gold standard. AxoSim's Nerve-on-a-Chip® delivers human data, faster to save you hundreds of millions of dollars and years of wasted patent life, while allowing you to develop more effective drugs.

Learn More

Breaking News
July 9th: AxoSim publishes first study confirming human myelination of human iPSC neurons in Scientific Reports.

Accuracy Icon

ACCURACY

Our technology enables researchers to predict human outcomes in the lab. We deliver accurate preclinical testing to help develop safer, more effective drugs.

Accuracy Icon

EFFICIENCY

Almost 90% of drugs that look promising in animal models fail when tested in humans, driving up the average cost and time of new drug development to $2.6 billion and 10 years or more. We deliver predictive human data in just weeks and at a fraction of the cost of in vivo studies.

Accuracy Icon

CLINICAL SUCCESS

Achieve the predictive readouts critical to your R&D success. We deliver clinically-relevant functional and structural metrics to improve success rates.

NERVE-ON-A-CHIP®

How it Works

AxoSim's Nerve-on-a-Chip® platform facilitates prediction of both clinical neurotoxicity and efficacy in human neurodegenerative disease models earlier in the drug development pipeline.

MINI-BRAIN

How it Works

The Mini Brain is a high quality 3D miniature brain organoid designed to serve as a human-relevant model in preclinical drug discovery.

News & Publications

Our Partners & Funders